Cargando…

The Emerging Role of Innate Immunity in Chronic Kidney Diseases

Renal fibrosis is a common fate of chronic kidney diseases. Emerging studies suggest that unsolved inflammation will progressively transit into tissue fibrosis that finally results in an irreversible end-stage renal disease (ESRD). Renal inflammation recruits and activates immunocytes, which largely...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Philip Chiu-Tsun, Zhang, Ying-Ying, Chan, Max Kam-Kwan, Lam, Winson Wing-Yin, Chung, Jeff Yat-Fai, Kang, Wei, To, Ka-Fai, Lan, Hui-Yao, Tang, Patrick Ming-Kuen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312694/
https://www.ncbi.nlm.nih.gov/pubmed/32512831
http://dx.doi.org/10.3390/ijms21114018
Descripción
Sumario:Renal fibrosis is a common fate of chronic kidney diseases. Emerging studies suggest that unsolved inflammation will progressively transit into tissue fibrosis that finally results in an irreversible end-stage renal disease (ESRD). Renal inflammation recruits and activates immunocytes, which largely promotes tissue scarring of the diseased kidney. Importantly, studies have suggested a crucial role of innate immunity in the pathologic basis of kidney diseases. This review provides an update of both clinical and experimental information, focused on how innate immune signaling contributes to renal fibrogenesis. A better understanding of the underlying mechanisms may uncover a novel therapeutic strategy for ESRD.